Attached files
file | filename |
---|---|
EX-99.1 - KEWAUNEE SCIENTIFIC CORP /DE/ | v204342_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
FORM
8-K
|
CURRENT
REPORT
|
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Date of Report (Date of earliest event reported) December 2, 2010 |
Kewaunee
Scientific Corporation
(Exact
name of registrant as specified in its charter)
|
Delaware
|
0-5286
|
38-0715562
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File
Number)
|
(I.R.S.
Employer
Identification
No.)
|
2700
West Front Street
Statesville,
North Carolina
(Address
of principal executive offices)
|
28677
(Zip
Code)
|
|||
Registrant’s
telephone number, including area code 704-873-7202
|
||||
N/A
(Former
name or former address, if changed since last report.)
|
||||
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
|
||||
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|||
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|||
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|||
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 2.02 Results of
Operations and Financial Condition
On
December 2, 2010, Kewaunee Scientific Corporation issued a press release
announcing its financial results for the second quarter ended October 31,
2010. A copy of the Press Release is furnished as Exhibit 99.1 to
this Current Report on Form 8-K.
Item 9.01 Financial
Statements and Exhibits
(d) Exhibits:
Exhibit
No.
99.1 Press
Release of Kewaunee Scientific Corporation dated December 2, 2010.
In
accordance with General Instruction B.2 of Form 8-K, the information in this
Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), or otherwise subject to the liabilities of that section,
and shall not be incorporated by reference into any registration statement or
other document filed under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in
such filing.
Signature
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
(Registrant)
|
|||
Kewaunee Scientific Corporation | |||
Date: December
2, 2010
|
By:
|
/s/
D. Michael Parker
|
|
D. Michael Parker | |||
Senior
Vice President, Finance
|
|||
Chief
Financial Officer
|